In a December 9, 2025 Washington Examiner op-ed, WLF Legal Policy Advisory Board member and former Food & Drug Administration (FDA) Chief Counsel, Dan Troy, criticized federal regulators’ approach to direct-to-consumer (DTC) advertising of prescription drugs.
On January 6, 2026, WLF urged the Supreme Court to grant review and reverse a Sixth Circuit decision that blessed certifying a disparate-impact damages class that included many uninjured members....
A recent oral argument revealed that whether Congress meant private parties to enforce part of a law regulating investment is a close question.
This site uses cookies for performance, site traffic analysis, and social media purposes. Find out more about our cookie policy here. You can adjust your preferences in cookie settings.
